Advances in Proteomics & Metabolomics 2023 - Day 2
Presentations will cover areas ranging from uncovering the molecular mechanisms of disease pathology, to the latest technological developments in diagnostics and treatment.
RECORD
|
Already taken place Th, 12.10.2023
Technology Networks
Advances in Proteomics & Metabolomics 2023 - Day1
Presentations will cover areas ranging from uncovering the molecular mechanisms of disease pathology, to the latest technological developments in diagnostics and treatment.
RECORD
|
Already taken place We, 11.10.2023
Technology Networks
The Hidden Pathophysiology of Lipids and Proteins in Alzheimer’s Revealed with Ion Mobility MS and Quantitative QQQ Biomarker Assays
The Hidden Pathophysiology of Lipids and Proteins in Alzheimer’s Revealed with Ion Mobility MS and Quantitative QQQ Biomarker Assays.
RECORD
|
Already taken place Tu, 10.10.2023
Agilent Technologies
What is Mass Spectrometry Imaging?
We will examine the types of MS imaging techniques on the market and the platforms on which they can be run.
RECORD
|
Already taken place Tu, 10.10.2023
Waters Corporation
Get the Perfect Answer for Synthetic Peptides & Oligonucleotides
Emerging therapies like Synthetic Peptides & Oligonucleotides are catching the attention due to its capabilities to improve their properties.
RECORD
|
Already taken place Th, 5.10.2023
Agilent Technologies
Powerful Multimodal Clinical Imaging System with LA-ICP-MS and MALDI-MS Microscopy
The Laser-ablation ICP-MS, which acquires information on the element distribution, and the award-winning iMScope QT MALDI-MS Microscope, which provide information on the compound distribution.
RECORD
|
Already taken place Th, 5.10.2023
Shimadzu Corporation
Accelerated Imaging Clarity
In our applications demo lab we will show the simplicity of changing between MALDI and DESI XS modes, both available on the MRT instrument.
RECORD
|
Already taken place We, 4.10.2023
Waters Corporation
Towards more Comprehensive Characterization of PFAS Exposure using Ion Mobility and High-Resolution Mass Spectrometry
Towards more Comprehensive Characterization of PFAS Exposure using Ion Mobility and High-Resolution Mass Spectrometry.
RECORD
|
Already taken place Tu, 3.10.2023
Agilent Technologies
Robust Multi-Level LC-MS Workflows for Biosimilar Comparability Assessment
Uses of the Xevo G3 QTof mass spectrometer in a case study of biosimilar mAb characterization at intact, subunit, and peptide level.
RECORD
|
Already taken place Th, 28.9.2023
Waters Corporation
Solving challenges in the determination of pyrrolizidine alkaloids via LC-MS/MS and LC-IM-HRMS
How our latest solutions meet industry demands, such as high throughput, enhanced sensitivity requirements, increased accuracy, and compliance.